Navigation Links
Gentiva(R) Health Services Acquisition Extends Certificate-of-Need Coverage in West Virginia
Date:7/1/2009

in of these and other factors that could cause actual results to differ from those contained in this news release, please refer to the Company's various filings with the Securities and Exchange Commission (SEC), including the "Risk Factors" section contained in the Company's annual report on Form 10-K for the year ended December 28, 2008.

    Financial and Investor Contact:       John R. Potapchuk
                                          631-501-7035
                                          john.potapchuk@gentiva.com

                                          or

                                          Brandon Ballew
                                          770-221-6700
                                          brandon.ballew@gentiva.com

    Media Contact:                        Jennifer Gery-Egan
                                          Brainerd Communicators
                                          212-986-6667
                                          gery@braincomm.com


'/>"/>
SOURCE Gentiva Health Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Gentiva(R) Health Services Acquires Louisiana Home Health Agency
2. Gentiva(R) Health Services to Present at Jefferies 3rd Annual Healthcare Conference
3. Gentiva(R) Health Services Receives Nasdaq Notification Regarding Independent Director Requirement
4. Gentiva(R) Health Services to Present at Deutsche Bank 34th Annual Health Care Conference
5. Gentiva(R) Health Services Schedules First Quarter Earnings Call and Web Cast for Thursday, April 30, 2009
6. Gentiva(R) Health Services to Present at Upcoming Investor Conferences
7. Gentiva(R) Health Services Sells Selected Pediatric Home Health Care Branches
8. Gentiva(R) Health Services Schedules Fourth Quarter and Fiscal 2008 Earnings Call and Web Cast for Wednesday, February 18, 2009
9. Gentiva(R) Health Services to Present January 13 at J.P. Morgan Healthcare Conference in San Francisco
10. Gentiva(R) Health Services to Present at November Investment Conferences Hosted by Oppenheimer, Credit Suisse and Stephens
11. Gentiva(R) Health Services Schedules Second Quarter Earnings Call and Web Cast for Thursday, July 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Long Beach, CA (PRWEB) May 21, 2013 ... the 3rd Annual EB-5 Investment Summit: Dealmakers Conference ... The Dealmakers Conference will focus on exploring alternative ... will provide the latest market, legal and economic ... executives, immigration and legal professionals within the EB-5 ...
(Date:5/21/2013)... Paris, France: The Orsiro stent, which is a ... polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting ... late lumen loss at nine months in the ... 2013 today. , The BIOFLOW-II substudy used intravascular ... quantitatively assess neointimal hyperplasia and stent apposition at ...
(Date:5/21/2013)... CA (PRWEB) May 21, 2013 According to ... to Rethink the Use of Botox,” Botox injections ... since their approval in 2002 (Go to goo.gl/8iYbD). Although it ... quite popular with men. The injection makes facial wrinkles less ... Botox injection last for about three months. This means that ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 The ... on cable networks and cable channels across the country, ... on its YouTube channel. The producers of the series ... in the shipping industry, the manufacturing industry, health-related companies, ... medical facilities and medical practitioners in all parts of ...
(Date:5/21/2013)... Diversity Focus, a non-profit organization striving ... residents in the Creative Corridor region, is releasing results ... news conference on Thursday, May 23rd at 10:30 a.m. ... 2008. , The survey is a critical ... efforts that attract, nurture and retain people of diverse ...
Breaking Medicine News(10 mins):Health News:Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California 2Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2
... as patient engagement, physician communication, and staff coordination may ... patient survival rates than others, according to a study ... Journal of the American Society of Nephrology (CJASN). ... figure out what top-performing dialysis units might be doing ...
... will receive a $2.3 million New Innovator Award today ... platelets and the technology that makes them work. ... to build platelets of biodegradable polymers, which link with ... and fellow researchers initially pursued the technology after seeing ...
... (BMC) has been awarded a four year, $5.7 million ... (NHLBI) for investigators from Boston University School of Medicine ... Cardiovascular Outcomes and Disparities. The goal of the Center ... health reform on cardiovascular (CV) care and outcomes, and ...
... Gardner HealthDay Reporter , WEDNESDAY, Sept. 29 (HealthDay ... younger women finds that screening can lower the risk of ... The study, done in Sweden, found that women who were ... 1,250 women five times over a 10-year period would save ...
... Kang Zhang, MD, PhD, professor of ophthalmology at the ... director of UCSD,s Institute of Genomic Medicine, has been ... Zhang and co-principal investigators Sheng Ding, PhD, from ... the University of Washington, received the highest possible scores ...
... of immunotherapy to children with neuroblastoma, a nervous system ... and free of disease progression after two years, according ... School of Medicine and fellow institutions. The percentage rose ... to 66 percent for children receiving immunotherapy plus standard ...
Cached Medicine News:Health News:Why do some dialysis centers have higher survival rates? 2Health News:Researchers to study effects of Mass. health reform 2Health News:Mammograms Save Lives for Women in Their 40s, Study Says 2Health News:Mammograms Save Lives for Women in Their 40s, Study Says 3Health News:UCSD receives NIH Transformative R01 Award for stimulation of neuron regeneration in the retina 2Health News:UCSD receives NIH Transformative R01 Award for stimulation of neuron regeneration in the retina 3Health News:Addition of immunotherapy boosts pediatric cancer survival in children with neuroblastoma 2
(Date:5/21/2013)... , May 21, 2013   Accuray ... today the publication of study results involving hundreds ... Robotic Radiosurgery System, the most widely used form ... study followed 304 patients for a median of ... and found that 97 percent of patients with ...
(Date:5/21/2013)... CITY, Calif. , May 21, 2013 ... point-of-care blood analysis systems, announced today that ... present at the Stifel Annual Dental & Veterinary Conference ... The conference will be held at Le Parker Meridien ... About Abaxis Abaxis develops, manufactures, ...
(Date:5/21/2013)... , May 21, 2013 Ceregene, Inc. ... analysis of its double-blind, randomized, controlled Phase 2b ... gene therapy product designed to deliver the neurotrophic ... identified a more robust response to CERE-120 in ... treatment relative to those diagnosed 10 years or ...
Breaking Medicine Technology:New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 2Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 4Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 5
... 2012  PAREXEL International Corporation (NASDAQ: PRXL ) will ... 2012 on Monday, January 30, 2012 after the close of ... website at www.PAREXEL.com and on the PR Newswire ... a conference call and live webcast at 10:00 a.m. ET ...
... 2012 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... application for BMN-111, an analog of C-type Natriuretic Peptide ... initiate the Phase 1 trial in the first quarter ... moderately and severely affected animal models and has been ...
Cached Medicine Technology:PAREXEL Announces Date of Second Quarter Fiscal Year 2012 Earnings Release and Conference Call 2BioMarin Announces IND for BMN-111 for Achondroplasia is Active 2BioMarin Announces IND for BMN-111 for Achondroplasia is Active 3BioMarin Announces IND for BMN-111 for Achondroplasia is Active 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: